---
title: "Tango Therapeutics ajukan program penjualan saham at-the-market hingga USD 400 juta"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295581692.md"
description: "Tango Therapeutics Inc. has expanded its at-the-market equity sales program through Leerink Partners, establishing a new offering cap of up to $400 million. The new supplemental prospectus includes approximately $35.61 million in unsold shares from the previous program, under which the company had already raised about $64.39 million. Sales under the prior prospectus have been halted, and future transactions will now proceed under this new supplemental filing."
datetime: "2026-08-11T21:14:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295581692.md)
  - [en](https://longbridge.com/en/news/295581692.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295581692.md)
generator: "portal-rs"
---

# Tango Therapeutics ajukan program penjualan saham at-the-market hingga USD 400 juta

-   Tango Therapeutics Inc. memperluas program penjualan saham at-the-market melalui Leerink Partners, dengan plafon penawaran hingga USD 400 juta. \* Prospektus suplement baru memasukkan sisa saham belum terjual senilai sekitar USD 35,61 juta dari program sebelumnya. \* Di bawah prospektus sebelumnya, perseroan telah menjual saham sekitar USD 64,39 juta. \* Penawaran berdasarkan prospektus sebelumnya dihentikan; penjualan selanjutnya akan dilakukan di bawah prospektus suplement baru. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-344997), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TNGX.US](https://longbridge.com/en/quote/TNGX.US.md)

## Related News & Research

- [Tema ETFs LLC Buys New Holdings in Tango Therapeutics, Inc. $TNGX](https://longbridge.com/en/news/295773782.md)
- [Tango Therapeutics President, R&D Crystal Adam disposes of USD 734,514 common shares](https://longbridge.com/en/news/295005668.md)
- [Evidence of unfair use: AI books squeeze human authors out of the market](https://longbridge.com/en/news/295947431.md)
- [Tango Therapeutics Q2 net loss widens as expenses rise](https://longbridge.com/en/news/295526669.md)
- [TAESA energizes Tangará synchronous compensator, adds R$ 5.4 million to annual revenue](https://longbridge.com/en/news/296137037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**